Anti-RTN4R ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The monoclonal antibodies which bind to the Nogo-66 receptor have utility in the treatment of several states including but not limited to mammalian brain trauma, spinal cord injury, stroke, neurodegenerative diseases, and schizophrenia.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-869 | Recombinant Anti-human RTN4R Antibody | WB, ELISA, IHC, FuncS | IgG |
MHH-869 | Recombinant Human Anti-human RTN4R Antibody | IF, WB, FuncS | IgG |
PABL-695 | Mouse Anti-RTN4R Recombinant Antibody (clone 1D9) | ELISA | Mouse IgG1 |
HPAB-0738-YJ | Human Anti-RTN4R Recombinant Antibody (M5) | ELISA, WB, FC, IF, IP, ICC | Chimeric (rabbit/human) IgG1, κ |
There are currently no Customer reviews or questions for AFC-520CL. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.